Molecular Markers and Targets in Modern Gynecologic Oncology
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: 31 December 2026 | Viewed by 129
Editors
Interests: gynecologic oncology; advance laparoscopic surgery; robotic surgery; clinical research
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Gynecologic oncology advancement is characterized by the continuous and increasing enrollment of molecular markers in daily clinical practice, not only as predictive tools but also as basic determinants of therapeutic management. Endometrial cancer guidelines set the molecular classification of disease as a primary component of the therapeutic algorithm, while regarding ovarian cancer, modern therapeutic modalities are tailored to molecular targets that are identified on an individualized base, in an effort to optimize prognosis. Management of cervical and vulvar cancer are relatively characterized by the implementation of relative strategies. In this context, this Special Issue extends a call for manuscripts related to the implementation of molecular targets in the modern therapeutic management of gynecological cancer. Original research articles, comprehensive reviews, systematic reviews and meta-analyses are the types of manuscripts that adhere to this Special Issue’s scope. We aim to compile a collection of high-quality evidence about molecular markers and targets in modern gynecologic oncology.
Dr. Stamatios Petousis
Dr. Chrysoula Margioula-Siarkou
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- endometrial cancer
- ovarian cancer
- cervical cancer
- vulvar cancer
- biomarker
- molecular classification
- targeted therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
